• Je něco špatně v tomto záznamu ?

Optimal Route for Tranexamic Acid in Diabetics and Obese Patients Undergoing Primary Total Knee Arthroplasty - a Data from Randomized Study [Optimální způsob podání tranexamové kyseliny u diabetiků a obézních pacientů - data z randomizované klinické studie]

J. Lošťák, J. Gallo, L. Baláž, J. Zapletalová

. 2020 ; 87 (6) : 429-437.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21003391

PURPOSE OF THE STUDY To determine the optimal strategy for tranexamic acid (TXA) administration in diabetic patients, smokers and obese patients (BMI > 30 kg/m2) undergoing primary total knee arthroplasty (TKA). MATERIAL AND METHODS The total of 400 consecutive patients indicated for primary TKA were randomised into 4 basic groups with different TXA administration regimens. Group 1 (IV1) had a single intravenous dose (15 mg TXA/kg) applied prior to skin incision. Group 2 (IV2) got two intravenous doses (15 mg TXA/kg): one prior to skin incision and one subsequently 6 hours after the first dose. Group 3 (TOP) had 2 g TXA in 50 ml of saline irrigated topically at the end of the surgery. Group 4 (COMB) combined IV1 and TOP regimens. We monitored the amount of total blood loss (TBL), haemoglobin drop, use of blood transfusions (BTs), and complications in each patient. Follow-up period was one year postoperatively. RESULTS In the group of diabetic patients (n = 87; 21.7%) the lowest TBL was observed in the order: IV1, IV2 > COMB > TOP. In the obese patients (BMI > 30 kg/m2; n = 242; 60.5%), TBL was significantly lower in the intravenous regimens (IV1: p = 0.002; IV2: p = 0.005, respectively) than in the TOP regimen. In the smoking patients (n = 30; 7.5%), TBLs were significantly lower in the order: IV1 > IV2 > COMB > TOP. DISCUSSION Individualised approach to prevention and therapy is a recent trend, also because comorbidities significantly affect the result of the intervention. In the case of diabetes, obesity and smoking, there is a proven link to early post-operative infections, mainly due to poorer innate immunity. It is conceivable, though, that the occurrence of infectious complications is also contributed to by larger hematomas or hemarthroses which are largely preventable. CONCLUSIONS In the diabetic and obese patients (BMI > 30 kg/m2), the combined topical/intravenous TXA application and two intravenous doses of TXA interventions were shown to be the most effective. However, no evidence of superiority of any of the TXA administration routes was obtained in the smokers. None of the TXA protocols was associated with a higher incidence of complications or early reoperation following TKA surgery. Key words: tranexamic acid, topical application, intravenous application, combined administration, diabetes, obesity, BMI, smoking, blood loss, hidden blood loss, total knee arthroplasty, complications.

Optimální způsob podání tranexamové kyseliny u diabetiků a obézních pacientů - data z randomizované klinické studie

000      
00000naa a2200000 a 4500
001      
bmc21003391
003      
CZ-PrNML
005      
20210211140228.0
007      
ta
008      
210202s2020 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)33408009
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lošťák, Jiří $7 xx0199227 $u Department of Orthopaedics, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc
245    10
$a Optimal Route for Tranexamic Acid in Diabetics and Obese Patients Undergoing Primary Total Knee Arthroplasty - a Data from Randomized Study / $c J. Lošťák, J. Gallo, L. Baláž, J. Zapletalová
246    31
$a Optimální způsob podání tranexamové kyseliny u diabetiků a obézních pacientů - data z randomizované klinické studie
520    9_
$a PURPOSE OF THE STUDY To determine the optimal strategy for tranexamic acid (TXA) administration in diabetic patients, smokers and obese patients (BMI > 30 kg/m2) undergoing primary total knee arthroplasty (TKA). MATERIAL AND METHODS The total of 400 consecutive patients indicated for primary TKA were randomised into 4 basic groups with different TXA administration regimens. Group 1 (IV1) had a single intravenous dose (15 mg TXA/kg) applied prior to skin incision. Group 2 (IV2) got two intravenous doses (15 mg TXA/kg): one prior to skin incision and one subsequently 6 hours after the first dose. Group 3 (TOP) had 2 g TXA in 50 ml of saline irrigated topically at the end of the surgery. Group 4 (COMB) combined IV1 and TOP regimens. We monitored the amount of total blood loss (TBL), haemoglobin drop, use of blood transfusions (BTs), and complications in each patient. Follow-up period was one year postoperatively. RESULTS In the group of diabetic patients (n = 87; 21.7%) the lowest TBL was observed in the order: IV1, IV2 > COMB > TOP. In the obese patients (BMI > 30 kg/m2; n = 242; 60.5%), TBL was significantly lower in the intravenous regimens (IV1: p = 0.002; IV2: p = 0.005, respectively) than in the TOP regimen. In the smoking patients (n = 30; 7.5%), TBLs were significantly lower in the order: IV1 > IV2 > COMB > TOP. DISCUSSION Individualised approach to prevention and therapy is a recent trend, also because comorbidities significantly affect the result of the intervention. In the case of diabetes, obesity and smoking, there is a proven link to early post-operative infections, mainly due to poorer innate immunity. It is conceivable, though, that the occurrence of infectious complications is also contributed to by larger hematomas or hemarthroses which are largely preventable. CONCLUSIONS In the diabetic and obese patients (BMI > 30 kg/m2), the combined topical/intravenous TXA application and two intravenous doses of TXA interventions were shown to be the most effective. However, no evidence of superiority of any of the TXA administration routes was obtained in the smokers. None of the TXA protocols was associated with a higher incidence of complications or early reoperation following TKA surgery. Key words: tranexamic acid, topical application, intravenous application, combined administration, diabetes, obesity, BMI, smoking, blood loss, hidden blood loss, total knee arthroplasty, complications.
650    _2
$a aplikace lokální $7 D000287
650    12
$a antifibrinolytika $7 D000933
650    12
$a totální endoprotéza kolene $x škodlivé účinky $7 D019645
650    _2
$a krvácení při operaci $x prevence a kontrola $7 D016063
650    12
$a diabetes mellitus $x farmakoterapie $7 D003920
650    _2
$a lidé $7 D006801
650    _2
$a obezita $x komplikace $7 D009765
650    12
$a kyselina tranexamová $7 D014148
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Gallo, Jiří $7 xx0019005 $u Department of Orthopaedics, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc
700    1_
$a Baláž, Ľuboš. $7 xx0257009 $u Department of Orthopaedics, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc
700    1_
$a Zapletalová, Jana $7 xx0111614 $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacký University Olomouc
773    0_
$w MED00011021 $t Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $x 0001-5415 $g Roč. 87, č. 6 (2020), s. 429-437
856    41
$u https://achot.cz/pdfs/ach/2020/06/08.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A8 $c 507 $y p $z 0
990    __
$a 20210202 $b ABA008
991    __
$a 20210210141534 $b ABA008
999    __
$a ok $b bmc $g 1619883 $s 1123692
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 87 $c 6 $d 429-437 $i 0001-5415 $m Acta chirurgiae orthopaedicae et traumatologiae Čechoslovaca $n Acta chir. orthop. traumatol. Čechoslovaca $x MED00011021
LZP    __
$b NLK118 $a Pubmed-20210202

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...